bridion

bridion Uses, Dosage, Side Effects, Food Interaction and all others data.

bridion is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery in adults. Rocuronium bromide and vecuronium bromide are neuromuscular blocking medications that cause temporary paralysis and are especially useful for general anesthesia, ventilation, or tracheal intubation that patients may require for surgery. bridion provides a new treatment option to reverse the effects of those medications and possibly help patients recover sooner post-surgery. bridion (brand name Bridion) is marketed by Merck Sharp and Dohme, and was approved by the United States FDA on December 15, 2015.

Trade Name bridion
Availability Prescription only
Generic Sugammadex
Sugammadex Other Names Sugammadex
Related Drugs pyridostigmine, neostigmine, Mestinon, Bridion, edrophonium, Bloxiverz
Weight 100mg/ml,
Type Solution, Vial, Injection, Intravenous Solution
Formula C72H112O48S8
Weight Average: 2002.12
Monoisotopic: 2000.408874758
Protein binding

Sugammadex does not bind plasma proteins.

Groups Approved
Therapeutic Class
Manufacturer Merck Sharp & Dohme Limited, Patheon Italia S,p,a,, Merck Sharp & Dohme (uk) Limited
Available Country Saudi Arabia, Australia, Philippines, United Kingdom, United States, France, Italy, Netherlands, Portugal, Spain,
Last Updated: September 19, 2023 at 7:00 am
bridion
bridion

Uses

bridion is a modified gamma cyclodextrin used to reverse neuromuscular blockade induced by vecuronium bromide and rocuronium bromide which are agents used for anesthesia.

bridion is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery.

bridion is also used to associated treatment for these conditions: Neuromuscular blockade caused by vecuronium bromide

How bridion works

bridion is a modified gamma-cyclodextrin which forms very tight water soluble complexes at a 1:1 ratio with steroidal neuromuscular blocking drugs (rocuronium > vecuronium >> pancuronium). bridion creates a concentration gradient which favors movement of rocurionium from the neuromuscular junction into the plasma, which quickly reverses rocuronium-induced neuromuscular blockade. The free rocuronium in the plasma are then bound tightly to sugammadex, assisting the diffusion of the remaining rocuronium molecules out of the neuromuscular junction and increasing bound and free rocuronium in the plasma.

Toxicity

Patients with severe renal impairment (with creatinine clearance below 30 mL/min) should avoid use of drug as their clearance of the drug is reduced and there is inconsistent evidence about its safety in this subset of patients.

Food Interaction

No interactions found.

bridion Disease Interaction

Moderate: bleeding, liver dysfunction, renal impairment

Volume of Distribution

At steady state, the volume of distribution is 11-14 L in adult patients with normal renal function.

Elimination Route

bridion is administered intravenously.

Half Life

About 2 hours

Clearance

88L/min

Elimination Route

Renal excretion of unchanged product. >90 of dose is excreted within 24 hours. 0.02% is excreted in feces and air.

Innovators Monograph

You find simplified version here bridion

*** Taking medicines without doctor's advice can cause long-term problems.
Share